Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             134 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Absence of human papillomavirus sequences in epithelial breast cancer in a Mexican female population Herrera-Romano, Lisbeth
2011
29 3 p. 1515-1517
artikel
2 Additional chromosomal abnormalities detected by array comparative genomic hybridization in AML Costa, Ana Rosa S.
2011
29 3 p. 2083-2087
artikel
3 Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese population Chen, Jia-hong
2011
29 3 p. 1972-1984
artikel
4 An association between corticosteroid use and melanoma recurrence: a case report and review of the literature Lazarus, Mark
2011
29 3 p. 2018-2020
artikel
5 An essential role of PDCD4 in progression and malignant proliferation of gastrointestinal stromal tumors Ding, Lingling
2011
29 3 p. 1758-1764
artikel
6 Angiotensin-converting enzyme insertion/deletion polymorphism and the risk of prostate cancer in the Han population of China Wang, Xiao
2011
29 3 p. 1964-1971
artikel
7 A novel prognostic model for extranodal natural killer/T-cell lymphoma Huang, Jia-Jia
2011
29 3 p. 2183-2190
artikel
8 Anti-tumor immune responses in immune-reconstituted mice injected with a tumor vaccine He, Aili

29 3 p. 2261-2269
artikel
9 Anti-tumor immune responses in immune-reconstituted mice injected with a tumor vaccine He, Aili
2011
29 3 p. 2261-2269
artikel
10 A preliminary study on the expression of tumor-associated glycoprotein-72 in human gliomas Wang, Dongchun
2011
29 3 p. 2027-2031
artikel
11 A previously unreported malignancy of the thyroid Cetin, Bulent
2011
29 3 p. 1418-1420
artikel
12 Arsenic trioxide inhibits HCCLM3 cells invasion through de novo ceramide synthesis and sphingomyelinase-induced ceramide production Zhang, ShiHai
2011
29 3 p. 2251-2260
artikel
13 Association between P-glycoprotein and lymphoid antigen expression on myeloblasts versus therapy response and survival in de novo acute myeloid leukemia: long-term follow-up results Machaczka, Maciej
2011
29 3 p. 2070-2076
artikel
14 Association of clinical and pathological variables with survival in thymoma Aydiner, Adnan
2011
29 3 p. 2221-2228
artikel
15 Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival Guo, Li
2011
29 3 p. 1656-1662
artikel
16 Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematological recovery Ungerstedt, J. S.
2011
29 3 p. 2191-2199
artikel
17 Can ex vivo evaluation (testing) predict the sensitivity of CLL cells to therapy with purine analogs in conjunction with an alkylating agent? A comparison of in vivo and ex vivo responses to treatment Żołnierczyk, Jolanta D.
2011
29 3 p. 2111-2126
artikel
18 CD44+/CD24− cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast Tiezzi, Daniel Guimarães
2011
29 3 p. 1479-1485
artikel
19 Cerebellar glioneuronal tumor: a case report and review of the literature Mahta, Ali
2011
29 3 p. 2038-2039
artikel
20 Characteristics of colorectal cancer in the human immunodeficiency virus-infected African American population Kumar, Avishek
2011
29 3 p. 1773-1779
artikel
21 Characterization of ABL exon 7 deletion by molecular genetic and bioinformatic methods reveals no association with imatinib resistance in chronic myeloid leukemia Meggyesi, Nóra
2011
29 3 p. 2136-2142
artikel
22 Chemotherapy with concurrent brain and thoracic radiotherapy in brain-only metastases of treatment naive small-cell lung cancer: a phase II study Chen, Li-kun
2011
29 3 p. 1687-1692
artikel
23 CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis Xu, Peng
2011
29 3 p. 1643-1647
artikel
24 Clinical characteristics of patients with lymphoproliferative neoplasms in the setting of systemic autoimmune diseases Suvajdzic, Nada
2011
29 3 p. 2207-2211
artikel
25 Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women Zhao, Lin
2011
29 3 p. 1569-1575
artikel
26 Clinical relevance of a new pre-treatment laboratory prognostic index in patients with oral squamous cell carcinoma Grimm, M.
2011
29 3 p. 1435-1447
artikel
27 Clinical significance of serum hepatocyte growth factor and epidermal growth factor gene somatic mutations in patients with non-squamous non-small cell lung cancer receiving gefitinib or erlotinib Masago, Katsuhiro
2011
29 3 p. 1614-1621
artikel
28 Clinical value of Tiam1–Rac1 signaling in primary gallbladder carcinoma Du, Xilin
2011
29 3 p. 1873-1878
artikel
29 Clinicopathological significance and prognostic value of Xeroderma pigmentosum complementary group C (XPC) expression in sporadic breast cancer patients Bai, Xuefeng
2011
29 3 p. 1543-1553
artikel
30 Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer Wong, H.
2011
29 3 p. 1536-1542
artikel
31 Combination of narrow band imaging (NBI) and autofluorescence imaging (AFI) videobronchoscopy in endoscopic assessment of lung cancer extension Zaric, Bojan
2011
29 3 p. 1638-1642
artikel
32 Comparative study of the immunohistochemical expression of tissue inhibitors of metalloproteinases 1 and 2 between clearly invasive carcinomas and “in situ” trophoblast invasion Dimo, Blerta
2011
29 3 p. 2270-2275
artikel
33 Compensatory and non-compensatory effects on protein expression following BCL-2 suppression by antisense oligonucleotides Rubenstein, Marvin
2011
29 3 p. 2284-2290
artikel
34 Comprehensive assessment of prognostic factors predicting outcome in Chinese patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide Xu, Min
2011
29 3 p. 2102-2110
artikel
35 Correlational study of vascular endothelial growth factor expression and microvessel density in primary malignant gastric lymphoma Xie, Lin
2011
29 3 p. 1711-1715
artikel
36 Cytokine and endocrine signaling in prostate cancer Puente Vazquez, J.
2011
29 3 p. 1956-1963
artikel
37 Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma Chen, Xiao-Qian
2011
29 3 p. 1843-1849
artikel
38 Decreased expression of Nedd4L correlates with poor prognosis in gastric cancer patient Gao, Chengcheng
2011
29 3 p. 1733-1738
artikel
39 DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy Li, Dairong
2011
29 3 p. 1622-1628
artikel
40 Ectopic expression of guanylyl cyclase C and endogenous ligand guanylin correlates significantly with Helicobacter pylori infection in gastric carcinogenesis Zhang, Jian-Feng
2011
29 3 p. 1748-1757
artikel
41 Elevated content of osteopontin in plasma and tumor tissues of patients with laryngeal and hypopharyngeal carcinoma associated with metastasis and prognosis Li, Yong
2011
29 3 p. 1429-1434
artikel
42 Erratum to: High expression of MAGE-A10 cancer-testis antigen in triple-negative breast cancer Badovinac-Črnjević, Tanja
2012
29 3 p. 1592
artikel
43 Evaluation of molecular prognostic and predictive factors: an important step towards personalised treatment in non small cell lung cancer Tartarone, Alfredo
2011
29 3 p. 1599-1605
artikel
44 Evaluation of pirarubicin–cisplatin chemotherapy in the treatment for refractory and recurrent high-grade osteosarcoma: experience of a single institute Qi, Wei-Xiang
2011
29 3 p. 2229-2233
artikel
45 Expression and prognostic significance of a new tumor metastasis suppressor gene LASS2 in human bladder carcinoma Wang, Haifeng
2011
29 3 p. 1921-1927
artikel
46 Expression of N-myc downstream-regulated gene 1 in primary gallbladder carcinoma and its correlation with clinicopathological features and clinical outcome Zhang, Sheng-bin
2011
29 3 p. 1866-1872
artikel
47 Expression of Plakophilins (PKP1, PKP2, and PKP3) in breast cancers Demirag, Guzin Gonullu
2011
29 3 p. 1518-1522
artikel
48 Expression pattern of ATM and cyclin D1 in ductal carcinoma, normal adjacent and normal breast tissues of Iranian breast cancer patients Salimi, Mahdieh
2011
29 3 p. 1502-1509
artikel
49 Extrapulmonary small cell: a novel case of small cell carcinoma of the thyroid gland Beach, Douglas F.
2011
29 3 p. 1405-1408
artikel
50 Fatal pneumonitis after treatment with pegylated liposomal doxorubicin in a patient with metastatic breast cancer in complete remission Mark, Michael
2011
29 3 p. 1477-1478
artikel
51 Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in breast cancer patients: a retrospective analysis Ngamphaiboon, Nuttapong
2011
29 3 p. 1495-1501
artikel
52 Fluorescence in situ hybridization analysis of chromosome aberrations in 60 Chinese patients with multiple myeloma Gao, Xiao
2011
29 3 p. 2200-2206
artikel
53 Folate metabolism-related gene polymorphisms and susceptibility to primary liver cancer in North China Cui, Lian-Hua
2011
29 3 p. 1837-1842
artikel
54 Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs Emile, J. F.
2011
29 3 p. 1765-1772
artikel
55 Frequency of HCV infection in renal cell carcinoma patients Budakoğlu, Burçin
2011
29 3 p. 1892-1895
artikel
56 GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma Spano, Jean-Philippe
2011
29 3 p. 1421-1428
artikel
57 Gender differences in lung cancer mortality trends in Andalusia 1975–2008: a joinpoint regression analysis Cayuela, Aurelio
2011
29 3 p. 1593-1598
artikel
58 Genetic alterations of the WWOX gene in breast cancer Ekizoglu, Seda
2011
29 3 p. 1529-1535
artikel
59 Genetic variants of MnSOD and GPX1 and susceptibility to bladder cancer in a Turkish population Kucukgergin, Canan
2011
29 3 p. 1928-1934
artikel
60 GGCn polymorphism of eRF3a/GSPT1 gene and breast cancer susceptibility Miri, Mahboobe
2011
29 3 p. 1581-1585
artikel
61 Girdin protein: a new potential distant metastasis predictor of breast cancer Liu, Caigang
2011
29 3 p. 1554-1560
artikel
62 Heart fatty acid-binding protein may not be an early biomarker for anthracycline-induced cardiotoxicity in rabbits Lai, Ren-chun
2011
29 3 p. 2303-2308
artikel
63 High expression of MAGE-A10 cancer-testis antigen in triple-negative breast cancer Tanja, Badovinac Črnjević
2011
29 3 p. 1586-1591
artikel
64 High expression of S100A11 in pancreatic adenocarcinoma is an unfavorable prognostic marker Xiao, Ming-Bing
2011
29 3 p. 1886-1891
artikel
65 Imatinib has the potential to exert its antileukemia effects by down-regulating hERG1 K+ channels in chronic myelogenous leukemia Zheng, Fang
2011
29 3 p. 2127-2135
artikel
66 Immunohistochemical detection of HSP27 and hnRNP K as prognostic and predictive biomarkers for colorectal cancer Wang, Feng
2011
29 3 p. 1780-1788
artikel
67 Impairment of breast cancer cell invasion by COX-2-specific inhibitor NS398: roles of CXCR4 and of uPA system Silva, Henriqueta Coimbra
2011
29 3 p. 1468-1476
artikel
68 Increased serum level of Nup88 protein is associated with the development of colorectal cancer Zhao, Zeng-Ren
2011
29 3 p. 1789-1795
artikel
69 Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection Chen, Kang-jie
2011
29 3 p. 1817-1826
artikel
70 Leptin and breast cancer: an overview Artac, Mehmet
2011
29 3 p. 1510-1514
artikel
71 Leptomeningeal carcinomatosis from ovarian cancer Miller, Eliza
2011
29 3 p. 2010-2015
artikel
72 Letter to the editor regarding the article by Uzunoglu et al Savranlar, Yasemin
2011
29 3 p. 2220
artikel
73 Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation Lai, Ming-chun
2011
29 3 p. 1810-1816
artikel
74 Long-term chemotherapy may prolong survival in advanced non-small-cell lung cancer among responders to first-line chemotherapy Hirashima, Tomonori
2011
29 3 p. 1629-1637
artikel
75 Loss of Bad expression confers poor prognosis in non-small cell lung cancer Huang, Yi
2011
29 3 p. 1648-1655
artikel
76 Mantle cell lymphoma successfully treated in a patient with multiple endocrine neoplasia type 2: a rare combination of two malignancies Machaczka, Maciej
2011
29 3 p. 2174-2175
artikel
77 Matrix metalloproteinase-9 is consistently expressed in Hodgkin/Reed-Sternberg cells and has no impact on survival in patients with Epstein–Barr virus (EBV)-related and non-related Hodgkin lymphoma in Brazil Souza, Eni M.
2011
29 3 p. 2148-2152
artikel
78 Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreement Porta, C.
2011
29 3 p. 1896-1907
artikel
79 Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese Pang, Da
2011
29 3 p. 1561-1568
artikel
80 MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis Chen, Lan-tao
2011
29 3 p. 1673-1680
artikel
81 Microsatellite instability in metastatic colorectal cancer: a review of pathology, response to chemotherapy and clinical outcome Yim, Kein-Leong
2011
29 3 p. 1796-1801
artikel
82 MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance Luo, Liang
2011
29 3 p. 1681-1686
artikel
83 miR-203 expression predicts outcome after liver transplantation for hepatocellular carcinoma in cirrhotic liver Chen, Hong-Yuan
2011
29 3 p. 1859-1865
artikel
84 NDRG2 down-regulation and CD24 up-regulation promote tumor aggravation and poor survival in patients with gallbladder carcinoma Song, Shi-peng
2011
29 3 p. 1879-1885
artikel
85 Neoadjuvant concurrent chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced esophegeal cancer Wahba, Hanan Ahmed
2011
29 3 p. 1693-1698
artikel
86 Old issues and new perspectives on prostate cancer hormonal therapy: the molecular substratum Reis, Leonardo Oliveira
2011
29 3 p. 1948-1955
artikel
87 Outcome prediction of advanced mantle cell lymphoma by international prognostic index versus different mantle cell lymphoma indexes: one institution study Todorovic, Milena
2011
29 3 p. 2212-2219
artikel
88 Overexpression of a disintegrin and metalloprotease 8 in human gliomas is implicated in tumor progression and prognosis He, Shiming
2011
29 3 p. 2032-2037
artikel
89 Overexpression of AQP5 in cervical cancer: correlation with clinicopathological features and prognosis Zhang, Ting
2011
29 3 p. 1998-2004
artikel
90 Overexpression of Y-box binding protein-1 in cervical cancer and its association with the pathological response rate to chemoradiotherapy Zhang, Y.
2011
29 3 p. 1992-1997
artikel
91 Patterns of imaging failures in glioblastoma patients treated with chemoradiation: a retrospective study Pan, Hubert
2011
29 3 p. 2040-2045
artikel
92 Phase I and pharmacokinetic study of trabectedin 3-hour infusion every three weeks in patients with advanced cancer and alteration of hepatic function Pardo, Beatriz
2011
29 3 p. 2240-2250
artikel
93 Phase I clinical trial of continuous infusion of tyroserleutide in patients with advanced hepatocellular carcinoma Xiao, Zhen-Yu
2011
29 3 p. 1850-1858
artikel
94 Polymorphism in pre-miR-30c contributes to gastric cancer risk in a Chinese population Mu, Yong-ping
2011
29 3 p. 1723-1732
artikel
95 P53 protein profile by IHC may be helpful to define patient prognosis Marcello, Marjory Alana
2012
29 3 p. 2309-2310
artikel
96 Preoperative docetaxel/cisplatin/5-fluorouracil chemotherapy in patients with locally advanced gastro-esophageal adenocarcinoma Bayraktar, Ulas Darda
2011
29 3 p. 1707-1710
artikel
97 Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer Asher, V.
2011
29 3 p. 2005-2009
artikel
98 Primary malignant melanoma of the female urethra: 10-year survival Altarac, Silvio
2011
29 3 p. 2016-2017
artikel
99 Primary mucinous adenocarcinoma of the bladder: complete response with FOLFOX-4 regimen Tatli, A. M.
2011
29 3 p. 1935-1937
artikel
100 Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients Xu, Peng-Peng
2011
29 3 p. 2176-2182
artikel
101 Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17) Wiernik, Peter H.
2012
29 3 p. 2095-2101
artikel
102 Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia Djunic, Irena
2011
29 3 p. 2077-2082
artikel
103 Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer Al-Moundhri, M. S.
2011
29 3 p. 1739-1747
artikel
104 Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma Hui, Marco K. C.
2011
29 3 p. 1699-1706
artikel
105 Prognostic significance of tumor location in high-grade non-muscle-invasive bladder cancer Vukomanovic, Ivana
2011
29 3 p. 1916-1920
artikel
106 Prostate-specific membrane antigen: a new potential prognostic marker of osteosarcoma Zeng, Chao
2011
29 3 p. 2234-2239
artikel
107 Proteome analysis of the effects of sorafenib on human hepatocellular carcinoma cell line HepG2 Suo, Aili
2011
29 3 p. 1827-1836
artikel
108 Retrospective analysis of seventy-one patients with neuroendocrine tumor and review of the literature Dogan, Mutlu
2011
29 3 p. 2021-2026
artikel
109 Risk of nasopharyngeal carcinoma associated with polymorphic lactotransferrin haplotypes Zhou, Yanhong
2011
29 3 p. 1456-1462
artikel
110 Role of the recently identified dysadherin in E-cadherin adhesion molecule downregulation in head and neck cancer Georgolios, Alexandros
2011
29 3 p. 1463-1467
artikel
111 Role of urokinase plasminogen activator receptor (CD87) as a prognostic marker in acute myeloid leukemia Atfy, Maha
2011
29 3 p. 2063-2069
artikel
112 Sequential therapy in metastatic renal cell carcinoma: what comes next? Porta, Camillo
2011
29 3 p. 1914-1915
artikel
113 Sequential use of sorafenib and sunitinib in advanced renal cell carcinoma: does the order of sequencing matter? Calvani, N.
2011
29 3 p. 1908-1913
artikel
114 Serum macrophage colony-stimulating factor (M-CSF) in patients with Hodgkin lymphoma Kowalska, Maria
2011
29 3 p. 2143-2147
artikel
115 Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy Wang, Liang
2011
29 3 p. 2153-2158
artikel
116 Soluble Fas and Fas ligand and prognosis in children with acute lymphoblastic leukemia Fathi, Mina
2011
29 3 p. 2046-2052
artikel
117 Strong cross-talk between angiogenesis and EBV: do we need different treatment approaches in lymphoma cases with EBV and/or high angiogenic capacity Paydas, Semra
2011
29 3 p. 2159-2165
artikel
118 Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia EL-Khodary, Noha M.
2011
29 3 p. 2053-2062
artikel
119 T-cell receptor gene rearrangement in Epstein–Barr virus infectious mononucleosis Marbello, L.
2011
29 3 p. 2300-2302
artikel
120 The adeno-associated virus-mediated HSV-TK/GCV suicide system: a potential strategy for the treatment of bladder carcinoma Pan, Jian Gang
2011
29 3 p. 1938-1947
artikel
121 The early addition of arsenic trioxide versus high-dose arabinoside is more effective and safe as consolidation chemotherapy for risk-tailored patients with acute promyelocytic leukemia: multicenter experience Huang, Bin-Tao
2011
29 3 p. 2088-2094
artikel
122 The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis Ying, Jieer
2011
29 3 p. 1716-1722
artikel
123 The expression of epidermal growth factor receptor and Ki67 in primary and relapse nasopharyngeal cancer: a micro-evidence for anti-EGFR targeted maintenance therapy Yang, Yanqin
2011
29 3 p. 1448-1455
artikel
124 The expression of Mcl-1 in human cervical cancer and its clinical significance Zhang, Ting
2011
29 3 p. 1985-1991
artikel
125 The relationship between Bmi-1 and the epithelial–mesenchymal transition in lung squamous cell carcinoma Huang, Jun
2011
29 3 p. 1606-1613
artikel
126 The role of RhoC in the proliferation and apoptosis of hepatocellular carcinoma cells Xie, Shuli
2011
29 3 p. 1802-1809
artikel
127 Thymidylate synthase expression is closely associated with outcome in patients with pulmonary adenocarcinoma Kaira, Kyoichi
2011
29 3 p. 1663-1672
artikel
128 TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage Dong, Hua-Jie
2011
29 3 p. 2166-2173
artikel
129 Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥10 g/dL: an exploratory analysis of a phase 3 trial Canon, Jean-Luc
2011
29 3 p. 2291-2299
artikel
130 Trastuzumab and lapatinib modulation of HER2 tyrosine/threonine phosphorylation and cell signaling Kostyal, D.
2011
29 3 p. 1486-1494
artikel
131 Type 2 diabetes mellitus and prognosis in early stage breast cancer women Kaplan, Muhammet Ali
2011
29 3 p. 1576-1580
artikel
132 Unexpected effect of the monoclonal antibody Panitumumab on human cancer cells with different KRAS status Tiemann, Nina
2011
29 3 p. 2276-2283
artikel
133 Urban and non-urban disparities in the use of post-mastectomy radiation for breast cancer Martinez, Steve R.
2011
29 3 p. 1523-1528
artikel
134 ZCCHC12, a potential molecular marker of papillary thyroid carcinoma: a preliminary study Li, Qiu-li
2011
29 3 p. 1409-1417
artikel
                             134 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland